ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Gene Prediction Tools Market to reach USD 507.65 million by 2030, Demand for Accurate Computational Analysis Drive New Opportunities

Mordor Intelligence has published a new report on gene prediction tools market offering a comprehensive analysis of trends, growth drivers, and future projections.

-- Introduction  

The gene prediction tools market is witnessing steady interest as research groups, genomic laboratories, and bioinformatics teams rely on advanced computational approaches to interpret DNA sequences. According to the findings presented in the Mordor Intelligence report, The gene prediction tools market size stands at USD 221.54 million in 2025 and is forecast to reach USD 507.65 million by 2030, delivering an 18.04% CAGR over the period, supported by wider sequencing activity, increased genome annotation programs, and software-driven insights for complex organisms. As genomic datasets expand, demand rises for tools capable of identifying gene locations, functional regions, and coding elements with reliable accuracy. 

Key Trends  

The gene prediction tools market trends reflect the industry's transition toward accuracy, workflow integration, and scalable genomic analysis environments. Several patterns are shaping how vendors refine their offerings and how end users adopt these solutions. 

1. Increasing reliance on computational gene identification 

Research organizations are focusing more on computational approaches that reduce manual interpretation. Tools capable of automated gene boundary detection, coding region identification, and sequence annotation are gaining traction. As genomic data volume rises, researchers require systems that manage repetitive tasks and deliver consistent analytical results. 

2. Growing interest in cloud-based and web-enabled gene prediction systems 

Many institutions are adopting online platforms that allow teams to run predictive models without extensive local infrastructure. Cloud-enabled software helps manage storage, processing, and collaborative analysis efficiently. This increases accessibility for labs that handle multiple genomes or time-sensitive analysis projects. 

3. Expanded integration into genomic research pipelines 

Gene prediction is increasingly embedded in wider bioinformatics workflows, including genome assembly, annotation, and comparative genomics research. Tools that align seamlessly with existing pipelines are preferred because they support continuous analysis from sequencing output to functional interpretation. 

4. Algorithm improvement and updated training datasets 

Modern gene prediction models designed for prokaryotic and eukaryotic systems rely on improved datasets, enhanced pattern-recognition logic, and better training sequences. This supports higher accuracy for complex genome structures and helps researchers refine annotation reliability. 

Market Segmentation  

The gene prediction tools market analysis outlined in the Mordor Intelligence report segments the landscape by solution type, application, and end user. Each segment plays a clear role in determining adoption patterns and software development focus. 

By Tool Type 

  • Ab initio Gene Prediction Software 
  • Evidence-driven Annotation Pipelines 
  • Integrated Genome Annotation Suites 
  • Cloud-based Gene Prediction APIs 

By Deployment Model 

  • On-premise 
  • Cloud / SaaS 

By Application 

  • Human Genomics 
  • Agrigenomics & Livestock 
  • Metagenomics & Microbiome 
  • Synthetic Biology & Pathway Design 

By End User 

  • Academic & Research Institutes 
  • Pharmaceutical & Biotech Companies 
  • CROs & CDMOs 
  • Hospitals & Diagnostic Labs 

By Geography 

  • North America 
  • South Amerca 
  • Middle east&Africa 
  • Europe 
  • Asia pacific 

Key Players | 

The competitive environment of the gene prediction tools market features a blend of academic-origin tools, commercial software providers, and specialized bioinformatics groups. These organizations continue to refine their platforms, update algorithmic performance, and support multi-organism compatibility. 

  • Illumina Inc. 
  • QIAGEN N.V. 
  • Thermo Fisher Scientific Inc. 
  • Softberry Inc. 
  • Geneious (Dotmatics) 

Key players focus on building reliable, well-documented tools that align with global genome research activity. Many offer both free access options and advanced commercial versions depending on the complexity of user requirements. Collaboration with genome sequencing centers, research universities, and bioinformatics service providers continues to strengthen the role of these tools in research ecosystems. 

Conclusion  

The gene prediction tools market remains essential for genome interpretation, helping researchers understand gene structures and functional elements across a wide range of species. As sequencing becomes more accessible and research institutions expand genome-focused programs, demand for streamlined and accurate prediction tools will remain steady. Continued emphasis on usability, cloud integration, and better predictive logic will help the market move toward improved accuracy and broader application. With consistent research engagement and evolving bioinformatics needs, the market is positioned for stable long-term development. 

Related Reports: 

Gene Synthesis Market: The Gene Synthesis Market is segmented based on synthesis methods, including chemical oligonucleotide synthesis and gene assembly, which encompasses PCR-mediated and ligation-mediated techniques. It is further categorized by service types, such as antibody DNA synthesis and other offerings, as well as by applications, including gene and cell therapy development and additional uses. The market also considers end users, ranging from biopharmaceutical companies to other relevant sectors, and is analyzed across key geographies, including North America, Europe, Asia-Pacific, and more.  

Gene Vector Market : The Gene Vector Market is segmented based on vector type, including viral vectors such as AAV and lentivirus, as well as by delivery method, encompassing both in-vivo and ex-vivo approaches. The market is further categorized by therapy area, covering oncology, genetic disorders, and other applications, along with end users such as biopharmaceutical companies. Additionally, segmentation includes the production workflow, comprising upstream and downstream processes, and geographic regions, including North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.  

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com      
https://www.mordorintelligence.com/         

About the company: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/

Contact Info:
Name: Jignesh Thakkar
Email: Send Email
Organization: Mordor Intelligence
Address: Hyderabad
Phone: +1617-765-2493
Website: https://www.mordorintelligence.com/

Release ID: 89178572

In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  231.57
+3.14 (1.38%)
AAPL  272.04
+1.07 (0.39%)
AMD  215.87
+0.92 (0.43%)
BAC  55.97
+0.09 (0.15%)
GOOG  315.83
+4.50 (1.45%)
META  664.83
+3.33 (0.50%)
MSFT  486.86
+1.94 (0.40%)
NVDA  188.28
+4.59 (2.50%)
ORCL  195.34
-3.04 (-1.53%)
TSLA  486.74
-1.99 (-0.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.